National Immunobiological Company (Nacimbio) has started this year's supplies of the flu vaccine to Russian regions as part of the national preventive vaccination campaign, Rostec informed.
Under the effective public contracts, Nacimbio will have supplied 34 million doses of domestic preventive drugs for children and adults to the Russian regions by the time the annual mass flu vaccination campaign starts in early autumn.
Nacimbio has been supplying vaccines for mass flu immunization since 2015. According to Russia's Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing (Rospotrebnadzor), the broader vaccination significantly curbs the flu scale in Russia; for example, in 2018, the number of cases decreased by more than 24% against the previous year.
Rostec is a Russian corporation established in 2007 to promote the development, production and export of hi-tech industrial products for civil and military purposes. It consists of more than 700 organizations untied in 11 holding companies specializing in the defense industry, 4 holding companies in the civil industrial segment, along with more than 80 directly managed entities. Rostec's portfolio includes famous brands such as AVTOVAZ, KAMAZ, Concern Kalashnikov, Russian Helicopters, VSMPO-AVISMA, Uralvagonzavod, etc. Rostec's organizations are located in 60 federal subjects of Russia and supply their products to the markets of more than 100 countries.
